Purchase Order 75F40120P00712
Award Date 9/29/20
Potential Completion Date 9/29/21
Potential Value $540K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Labor Hours
Place of Performance
Falls Church, VA 22042, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Iqvia Government Solutions Inc. was awarded a firm fixed price purchase order contract valued at $2,171,621.71 by the Department of Health and Human Services' Food and Drug Administration to obtain access to data resources enabling global capture of pharmaceutical sales data by country. This contract delivers against the original solicitation requesting pharmaceutical sales information to support the FDA in monitoring drug markets internationally. It was awarded without a set-aside designation...
- This is a firm fixed price purchase order awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Iqvia Government Solutions Inc., a provider of healthcare data, analytics, and related services to U.S. federal agencies. The contract, valued at $323,318.80, is for the delivery of pharmaceutical data to support COVID-19 response efforts. Iqvia has previously supported HHS components such as the Food and Drug Administration (FDA), Centers for...
- The Food and Drug Administration (FDA) awarded a $11,370,207.78 definitive, firm-fixed-price contract to Iqvia Government Solutions Inc. to provide ongoing access to national and international pharmaceutical sales data. This data will be used to estimate trends in drug sales, pricing, and volume of distribution to support the FDA's regulatory decision-making. The contract has a base period of one year with four one-year option periods, and there was no set-aside designation. Iqvia is a prominent...
- Iqvia Government Solutions Inc. has been awarded a $3,667,351.10 firm fixed price delivery order contract by the Department of Health and Human Services' Food and Drug Administration to provide hospital drug data. The contract has no set-aside designation and work will be performed in Silver Spring, Maryland through April 2025. This delivery order was issued against Iqvia's indefinite delivery, indefinite quantity contract vehicle worth up to $9 million to supply hospital drug data in support of...
- Iqvia Government Solutions Inc. has been awarded a $734,806 firm fixed price contract by the Department of Health and Human Services' Food and Drug Administration to deliver the ACCESS TO DATA SETS SMART SOLUTIONS PLATFORM (SMART) & MEDICAL DEVICE SUPPLY AUDIT (MDSA). No set-aside designation was used. Performance will take place in Silver Spring, Maryland through September 2023. Iqvia holds several FDA indefinite delivery vehicles to provide healthcare data and related services, including a...
- The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $308,625.00 purchase order contract to NMD Group, LLC, a woman-owned small business, to support the FDA's planning for real-world data and real-world evidence related to COVID-19. The contract has a completion date of September 7, 2021 and is structured as a labor hours contract. This contract award appears to be part of the FDA's efforts to accelerate planning and utilization of real-world data and...
- This is a firm fixed price delivery order contract awarded by the Department of Health and Human Services' Food and Drug Administration (FDA) to Iqvia Government Solutions Inc., a provider of healthcare data, analytics, and related services. The contract is for access to over-the-counter drug utilization data, with a potential value of $399,769.88 and a completion date of September 27, 2023. Iqvia has provided similar data and analytics services to the FDA, Centers for Disease Control and...
- This is a firm fixed price delivery order awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Iqvia Government Solutions Inc., a for-profit provider of healthcare data, analytics, and related services to U.S. federal agencies. The order, valued at $550,923.02, is for "International Sales Data" and has a completion date of February 1, 2019. Iqvia has held multiple prime and subcontracts with the FDA and other agencies to provide prescription drug...
- The Department of Health and Human Services Food and Drug Administration awarded a $2,461,558.38 Definitive Contract on a Time and Materials basis to Iqvia Government Solutions Inc., a healthcare data and analytics provider, to develop new, innovative methods for automation of blood product adverse event reporting under the Biologics Effectiveness and Safety (BEST) Initiative. This contract does not have a set-aside designation. Iqvia provides a range of healthcare data and analytics services to...
- The Department of Health and Human Services awarded a $1.5 million firm fixed price delivery order contract to Iqvia Government Solutions Inc. under the Chief Information Officer Commodities and Solutions government-wide acquisition contract. The contract calls for COVID-19 health care data subscription services to support the Office of the Assistant Secretary for Administration. Performance will take place in Mosby, Virginia through September 2023. Iqvia will provide data and analytics to...
The Department of Health and Human Services Food and Drug Administration awarded a $539,809 purchase order contract to Iqvia Government Solutions Inc. of Mosby, Virginia to provide COVID-19 real-world evidence/data agile analytics and specialized data sets. Under this contract, Iqvia will leverage its expertise in data analytics to support the FDA's efforts to monitor the real-world impact of COVID-19 through analysis of specialized data sets. The one-year contract commenced on September 29, 2020 and is set to conclude on September 29, 2021. No subcontractors or set-aside designations were identified. This award advances the FDA's mission to protect public health through regulatory science initiatives during the ongoing COVID-19 pandemic.
Generated 12/25/23, 2:40 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Change Order | $0 | 1/25/21 | |
| Not listed | Not listed | $539.8k | 9/29/20 |